logo-loader

Zosano Pharma Corp

Receive alerts
Market:
NASDAQ
Market Cap:
$37.22 m
Price
2.10 USD
Change
8.25%
52 weeks high
6.65
52 weeks low
1.42

In brief

Zosano Pharma Corporation is a clinical-stage biopharmaceutical company focused on providing systemic administration of therapeutics to patients using our proprietary Adhesive Dermally-Applied Microarray, or ADAM technology. Our lead clinical asset, M207, has completed the pivotal ZOTRIP trial. Zosano is focused on developing products where rapid administration of established molecules with known safety and efficacy profiles provides an increased benefit to patients, for markets where patients remain underserved by existing therapies.